PM reported its eleventh earnings triple play in its history and the first since February 2023. Click to read.

The number of oral medications patients on hemodialysis take appears to be among the factors affecting their cardiovascular risk.

Emerging market debt’s composition, risk, return, and correlation characteristics have transformed over the years. Click to ...

SIPs over the past 3-years have yielded a return in excess of 15% p.a. on an average for the top quartile equity funds.

Biohaven focuses on innovative treatments for neurological and other serious conditions. With an average target price of $61.48, analysts consider Biohaven a Strong Buy due to its broad pipeline and ...

It languished in the third quartile of the IA UK All Companies sector over five and three years and is in the bottom quartile ...

Consumers’ 2022 and 2023 CAIDI metrics both including and excluding MEDs were in the 4th Quartile, worse than average among ...